1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Proteins: new trials by email Literature Review of Proteins trials Research Report on Proteins
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Metabolic Resuscitation for Septic Shock Best Practice, early metabolic resuscitation - Multiple Organ Failure, Septic Shock | Phase 2 | Terminated | M.D. Anderson Cancer Center | 2 | 2019-10-04 | 2024-10-29 |
| Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults DNA-HIV-PT123 vaccine, Bivalent Subtype C gp120/MF59 vaccine, Bivalent Subtype C gp120/AS01B vaccine - HIV Infections | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 334 | 2016-12-07 | 2022-04-29 |
HIV Infections (1) · Multiple Organ Failure (1) · Sepsis (1) · Shock, Septic (1)
M.D. Anderson Cancer Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2) · South Africa (1)
Joseph L. Nates, MBA,MD (1) · Nigel Garrett (1)
PMID 30282622, PMID 34895272, PMID 38916429, PMID 40190112, PMID 40704585
P30CA016672 (1)